Inventiva (IVA) Cash from Financing Activities (2019 - 2022)

Inventiva's (IVA) quarterly Cash from Financing Activities came in at $14.2 million in Q4 2022, up 40038.88% year-on-year from N/an in Q4 2021, and down 2.22% quarter-over-quarter from $14.6 million in Q3 2022.

Inventiva (IVA) Cash from Financing Activities (2019 - 2022) Analysis & Trends

Inventiva's Cash from Financing Activities history runs 4 years deep, the most recent figure standing at $14.2 million for Q4 2022.

  • On a quarterly basis, Cash from Financing Activities rose 40038.88% year-over-year to $14.2 million in Q4 2022; TTM through Dec 2022 was $28.9 million, a 1.79% decrease from a year earlier, with the FY2025 full-year figure at $280.9 million, up 80.54% from the prior year.
  • Cash from Financing Activities declined to $14.2 million in Q4 2022 per IVA's latest filing, from $14.6 million in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $29.3 million in Q4 2020 and bottomed at -$132826.5 in Q4 2019.
  • The 4-year median for Cash from Financing Activities is $11.0 million (2020), against an average of $9.5 million.
  • Across the five-year window, Cash from Financing Activities plunged 100.12% in 2021 and surged 40038.88% in 2022, its largest moves.
  • Year by year, Cash from Financing Activities stood at -$132826.5 in 2019, then surged by 22187.97% to $29.3 million in 2020, then tumbled by 99.88% to $35463.1 in 2021, then jumped by 40038.88% to $14.2 million in 2022.
  • Per Business Quant, the three latest IVA Cash from Financing Activities figures stand at $14.2 million (Q4 2022), $14.6 million (Q3 2022), and $35463.1 (Q4 2021).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 30.14 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 68.63 Mn
4 NuCana 279.75 Bn 279.75 Bn - 9,311.16
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -538.80 Mn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -802.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - 238.74 Mn
10 Inventiva 842.48 Mn 842.48 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2022 14.23 Mn
Dec 31, 2022 14.23 Mn
Sep 22, 2022 14.56 Mn
Sep 22, 2022 14.56 Mn
Dec 31, 2021 35,463.10
Dec 31, 2021 35,463.10
Jun 30, 2021 56,600.76
Jun 30, 2021 56,600.76
Mar 31, 2021 -19,299.78
Mar 31, 2021 -19,299.78
Dec 31, 2020 29.34 Mn
Dec 31, 2020 29.34 Mn
Jun 30, 2020 10.99 Mn
Jun 30, 2020 10.99 Mn
Mar 31, 2020 16.15 Mn
Mar 31, 2020 16.15 Mn
Dec 31, 2019 -132,826.52
Dec 31, 2019 -132,826.52